CalciMedica (CALC) EBITDA Margin Growth (1y) (2025 - 2026)
CalciMedica (CALC) EBITDA Margin Growth (1y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | -1,651.00 |
| 10 | CalciMedica | 9.83 Mn | -8.78 Mn | - | -488,590.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -488,590.00 |
| Mar 31, 2026 | -1,756.00 |
| Dec 31, 2025 | 540,423.00 |
| Sep 30, 2025 | -35,006.00 |
| Jun 30, 2025 | 459,697.00 |
| Mar 31, 2025 | 145,784.00 |